Dr. White received the B.S. and M.S degrees in chemistry from Jackson State University in Jackson, MS and his Ph.D. in Analytical Chemistry from the University of North Carolina at Chapel Hill, NC where he specialized in mass spectrometry. He began his career as a forensic toxicologist with the University of Mississippi Med Center/MS State Crime Laboratory. Following the completion of his Ph.D., he joined RJ Reynolds Tobacco Co. until 1998 when Dr. White accepted a position with Large Scale Biology Corporation (LSBC) as a Senior Scientist. There he established The Analytical Center of Excellence and was subsequently promoted to Director of Advanced Analytical Resources and Quality Control for LSBC's Non-Hodgkin’s Lymphoma (NHL) cancer vaccines program, the company's first clinical product candidate. In 2002, he was appointed Vice President, Advanced Analytical Sciences. In addition to his role as Vice President of Advance Analytical Sciences for LSBC and Predictive Diagnostics, Inc. (PDI). From July 2007 until 2008 Dr. White served as Vice President, Analytical and Pharmaceutical Sciences for Integrated Biomolecule Corporation. Dr. White founded MDx Laboratory, Inc. in 2008 drawing upon his experience to focus his expertise in the field of biomolecular characterization. He later accepted a position as Director of Quality Labs with Caliber Biotherapeutics and served as Director of R&D/Quality Labs until the facility was acquired by iBio where he served as VP of R&D. In addition to his career in the private sector Dr. White served and retired from the US Army Reserve after over 34 years achieving the rank of Lieutenant Colonel.

Dr. Roychowdhury’s career in Drug Discovery and Development spans over 15 years.

Dr. Earl White, President & CEO

Dr. White’s career in biotechnology and biopharmaceutical research and development spans over 40 years and includes technical and executive leadership roles.​​

 

Dr. Roychowdury received his MS from Kanpur University, UP, India and PhD from Central Drug Research Institute, Lucknow, UP, India in the area of Medicinal Chemistry. His career begins at IIT Mumbai as a Research Officer working on both synthetic and analytical development of COX-2 inhibitors. Later, he accepted the postdoctoral fellowship at the Chemistry department, University of Florida, Gainesville, Fl in the areas of Nucleosides and Nucleotides. Since then, he has have worked in Academia, Industry and CMOs. Over the years he has had a wide range of successful experience in the areas of design, synthesis, purification, analysis and development of the methods for process and analytics. His experiences range from small molecule to large ones; heterocycles, carbohydrates, amino acids, nucleosides and nucleotides, fatty acids, lipids, human monoclonal antibodies and nanoparticles. Dr Roychowdury possess four patents, twenty publications and presentations. He is an editor of Nucleosides Nucleotides and Nucleic Acids and Drug Discovery & Development and Current Pharmaceutical Design. Dr. roychowdury has been awarded as Outstanding Accomplisher for four consecutive years, 2006 – 2009 at Southern Research Institute, Birmingham, Al. He has been appointed as reviewer on NSF for US Census Bureau from 2010 – 2011.

Dr. Roychowbury brings the knowledge and experience of working on the interface of chemistry and biology within the strict regulatory guidelines here.

Dr. Earl White, President & CEO

Dr. White’s career in biotechnology and biopharmaceutical research and development spans over 40 years and includes technical and executive leadership roles.​​

Meet our team

"defining biomolecular characterization"